Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × HER2-positive Breast Cancer × Letrozole × Clear all

Sponsor

Conditions

Breast Neoplasms 100 Neoplasm Metastasis 5 Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Neoplasms, Male 4 Arthralgia 4 Ovarian Neoplasms 3 Osteoporosis 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 2 Polycystic Ovary Syndrome 2 Pain 2 Leiomyosarcoma 2 Leiomyoma 2 Infertility 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Recurrence 1 Ovarian Cysts 1 Osteitis Deformans 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1 Lymphangioleiomyomatosis 1 Lethal Congenital Contracture Syndrome 2 1 Hormone-sensitive Metastatic Breast Cancer 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Fractures, Bone 1

Interventions

pertuzumab 2 Trastuzumab 2 Docetaxel 2 tucatinib 1 Protons 1 Paclitaxel 1 Fulvestrant 1 Enfuvirtide 1 Doxorubicin 1 Cyclophosphamide 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡